Comparison of induced and spontaneous atrial tachyarrhythmias in patients with a history of spontaneous atrial tachyarrhythmias

被引:4
作者
Wollmann, CG
Birnie, D
Tang, A
Boriani, G
Kühl, M
Böcker, D
机构
[1] Univ Munster, Dept Cardiol & Angiol, D-4400 Munster, Germany
[2] Ottawa Heart Inst, Ottawa, ON, Canada
[3] Univ Bologna, Inst Cardiol, Bologna, Italy
[4] Guidant, Diegem, Belgium
关键词
tachyarrhythmias; atrial flutter; pacing; electrophysiology; implantable cardioverter defibrillator;
D O I
10.1111/j.1540-8167.2005.40726.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: This retrospective study investigated whether induced episodes could be used to predict the morphology of future spontaneous atrial episodes. Methods: Eighty-two patients (64 +/- 12 years; 77% male; CAD in 60%; left ventricular ejection fraction 45 +/- 16%) with a history of atrial tachycardia or atrial fibrillation (AT/AF) were implanted with a dual-chamber implantable cardioverter defibrillator (ICD) and followed for 6 months. A total of 224 episodes of induced and spontaneous AT/AF were classified into type I, II, and III according to the method of Israel et al. and then compared based on average cycle length (CL) and atrial amplitude. Episodes were also grouped as "pace-terminable" or "nonpace-terminable" based on the CL definition of Gillis et al. Results: The analysis of 121 induced episodes (from 80 patients) and 103 spontaneous episodes (from 43 patients) showed that within each arrhythmia type, there were no significant differences in CL or mean amplitude between induced and spontaneous episodes. Additional analysis of patients that had both induced and spontaneous episodes (n = 41) showed 78% had at least one spontaneous episode that matched the induced episode. Fifty-seven percent of spontaneous episodes were considered to be pace-terminable based on CL. Conclusions: Our data suggest that there is no significant difference between induced and spontaneous episodes of AT/AF of the same type. The majority of patients had at least one spontaneous episode of the same type as the induced episode, showing that induced atrial arrhythmias may be useful in predicting the morphology of future spontaneous episodes and in identifying patients potentially benefiting from atrial antitachycardia pacing.
引用
收藏
页码:818 / 822
页数:5
相关论文
共 11 条
[1]   Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator [J].
Adler, SW ;
Wolpert, C ;
Warman, EN ;
Musley, SK ;
Koehler, JL ;
Euler, DE .
CIRCULATION, 2001, 104 (08) :887-892
[2]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[3]   Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias [J].
Boriani, G ;
Wollmann, C ;
Biffi, M ;
Kühl, M ;
Schuchert, A ;
Sperzel, J ;
Stiller, S ;
Gasparini, G ;
Böcker, D .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (01) :461-465
[4]   Do patients accept Implantable atrial defibrillation therapy? Results from the patient atrial shock survey of acceptance and tolerance (PASSAT) study [J].
Burns, JL ;
Sears, SF ;
Sotile, R ;
Schwartzman, DS ;
Hoyt, RH ;
Alvarez, LG ;
Ujhelyi, MR .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (03) :286-291
[5]   Antitachycardia pacing therapies to terminate atrial tachyarrhythmias: the AT500 Italian Registry [J].
Disertori, M ;
Padeletti, L ;
Santini, M ;
Dini, P ;
Gasparini, M ;
Inama, G ;
Botto, M ;
Boriani, G ;
Capucci, A ;
Ricci, R ;
Gramegna, L ;
Del Greco, M ;
Grammatico, A ;
Vimercati, M .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0P) :P16-P24
[6]   Atrial therapies reduce atrial arrhythmia burden in defibrillator patients [J].
Friedman, PA ;
Dijkman, B ;
Warman, EN ;
Xia, A ;
Mehra, R ;
Stanton, MS ;
Hammill, SC .
CIRCULATION, 2001, 104 (09) :1023-1028
[7]   Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator [J].
Gillis, AM ;
Unterberg-Buchwald, C ;
Schmidinger, H ;
Massimo, S ;
Wolfe, K ;
Kavaney, DJ ;
Otterness, MF ;
Hohnloser, SH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (09) :1653-1659
[8]   Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients:: effects on therapy efficacy and atrial tachyarrhythmia burden [J].
Hügl, B ;
Israel, CW ;
Unterberg, C ;
Lawo, T ;
Geller, JC ;
Kennis, IM ;
Euler, DE ;
Koehler, JL ;
Hettrick, DA .
EUROPACE, 2003, 5 (04) :403-409
[9]   Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation:: Insights from a study using a new implantable device [J].
Israel, CW ;
Ehrlich, JR ;
Grönefeld, G ;
Klesius, A ;
Lawo, T ;
Lemke, B ;
Hohnloser, SH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) :355-363
[10]   Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system [J].
Schoels, W ;
Swerdlow, CD ;
Jung, W ;
Stein, KM ;
Seidl, K ;
Haffajee, CJ .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2001, 12 (05) :521-528